Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 34.31M P/E - EPS this Y - Ern Qtrly Grth -
Income -14.6M Forward P/E - EPS next Y - 50D Avg Chg -45.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -59.00%
Dividend N/A Price/Book 3.01 EPS next 5Y - 52W High Chg -75.00%
Recommedations - Quick Ratio 0.50 Shares Outstanding 321.13M 52W Low Chg 2.00%
Insider Own 2.49% ROA -42.52% Shares Float 317.76M Beta -0.20
Inst Own 1.71% ROE -82.86% Shares Shorted/Prior -/- Price 0.10
Gross Margin - Profit Margin - Avg. Volume 478,170 Target Price -
Oper. Margin - Earnings Date Feb 27 Volume 533,639 Change -6.82%
11/30/22 Revive Therapeutics Ltd. Announces Offering of Up to $5 Million
11/24/22 Revive Therapeutics Announces Update for Type C Meeting to Discuss Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
11/22/22 Revive Therapeutics Announces FDA Recommendation for Type C Meeting to Discuss Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
10/14/22 Revive Therapeutics Announces Finalization of Amended Phase 3 COVID-19 Study Protocol to FDA
10/06/22 Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
09/16/22 Revive Therapeutics Provides Update on the Psilocybin Clinical Study for Methamphetamine Use Disorder and Oral Psilocybin Thin Film Strip Program
09/14/22 Revive Therapeutics Announces Submission of Amended Phase 3 COVID-19 Study Protocol to FDA
05/31/22 Weekly Roundup on the Cannabis Sector & Psychedelic Sector
05/31/22 Revive Therapeutics Advances Inflammatory Liver Disorders Programs for Autoimmune Hepatitis and Liver Transplantation
04/25/22 PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business Highlights and Update
04/18/22 Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19
02/24/22 HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research
02/15/22 Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation
01/17/22 Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs
01/06/22 Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has research collaboration agreements with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; North Carolina State University for the development of a biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform; the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19; University of Health Sciences Antigua for the clinical research of psychedelics; and PharmaTher for the development of psilocybin microneedle patch. The company was incorporated in 2012 and is headquartered in Toronto, Canada.

RVVTF Chatroom

User Image Giplong Posted - 1 day ago

$RVVTF Where did this vixxy guy come from.? He is very concerned! Poor guy.

User Image TheVixFix Posted - 1 day ago

$RVVTF 0.09 soon.

User Image TheVixFix Posted - 1 day ago

$RVVTF @Christhemainstream @christhemain Sup. LMFAO.

User Image TheVixFix Posted - 1 day ago

$RVVTF OMG it's worse everytime I look LMFAO. YIKES. OUCH. So glad I sold at 0.33

User Image TheVixFix Posted - 1 day ago

$RVVTF OUCH! This is getting rekt so hard. Even on a great day for the sector. SMH. Get left in the dust. #rekt

User Image PREPAREyourRUMP Posted - 1 day ago

$RVVTF this golden ticket is covered in feces currently….oh well, still my ticket

User Image JoeBenson77 Posted - 1 day ago


User Image adaire Posted - 1 day ago

$RVVTF still believe in this but I'm done till January. Imo maybe a little bump when they submit the package when formally requesting the meeting? Otherwise this is dead money till mid/end January. Hopefully approval or BO end of February.

User Image 2duhmooon Posted - 1 day ago

$RVVTF 135000 shares at average price of 0.185 US. Hope much hope do I have for recooping my loses?

User Image Nero68 Posted - 1 day ago

$RVVTF I agree with whoever said if you’re so worried then you invested way too much. I bought 4800 shares in about 1500 bucks to me. This was a lotto ticket the whole way and I’ll never sell it till it hits 50 bucks.

User Image Nero68 Posted - 1 day ago

$RVVTF when does the dividend start? 😂

User Image rubyourdingus69 Posted - 1 day ago

$RVVTF disclaimer: I'm a noob. What's the smart move here? I have faith in buci but I'm starting to lose faith in the company. Thinking about cutting my losses but I don't know when to sell. (Or if I should just bite the bullet and hold on).

User Image dividendinvestorbyeagle Posted - 1 day ago

$RVVTF close decreased > 10% (Revive Therapeutics Ltd) https://www.dividendinvestor.com/dividend-news/?symbol=rvvtf

User Image Amessagefromtheodd Posted - 2 days ago

$RVVTF https://www.empr.com/home/news/safety-alerts-and-recalls/fda-pulls-authorization-for-bebtelovimab-due-to-nonsusceptible-sars-cov-2-variants/

User Image Hattrick3 Posted - 2 days ago

$RVVTF those investors that are royally pissed and believe that trial delays are only a Revive and MF thing you are obviously biotech newbs and welcome. Those that are extremely worried about the final outcome invested WAY too much! Those that are still chirping about “we should of went to Turkey” are lazy. We are all thrilled that you are not the CEO. Those that are shocked that a clinical stage biotech company had to raise some capital should not be investing; period. Those that are unhappy that a P3 trial is taking too long should never invest in a biotech firm again. Those that think this phase 3 trial business is easy; please count up for us all the pill form therapeutics that have been approved for mild/mod Covid. Because I care, I will do it for you. The answer is zero. Many have tried; all have failed to date. Have their been mis-steps; sure. Could the PRs be better; yep. Are we in the game; yes Sir! Is an approved drug still worth billions; absolutely.

User Image BirdB5 Posted - 2 days ago

$RVVTF Cheer up you whining duck asses!

User Image Nero68 Posted - 2 days ago

$RVVTF @TheVixFix dude, you are so ridiculously short and desperate that you embarrass yourself with each post. Lol 🤡

User Image TheVixFix Posted - 2 days ago

$RVVTF my god this is a trainwreck lol. Remember all the people bashing me when I told them to sell at .33 and .17 REKT LOL

User Image Giplong Posted - 2 days ago

$RVVTF No of this should come as big surprise! Anyone who has done their DD knew they needed the money for 2023. IMO it doesn’t change my thoughts. I’m still very bullish. It’s a little bit of an overreaction for a small bio company raising cash to continue R&D. If you are scared of this happening then go invest in JnJ

User Image Thoughtless Posted - 2 days ago

$RVVTF If this all works out, clearly it's not because management is good at what they do

User Image TheVixFix Posted - 2 days ago

$RVVTF MF stole all your money! LOLOLOLOL

User Image Meshuggah Posted - 2 days ago

$RVVTF All they needed….was 1000 patients, during a time where 10’s of thousands were getting it every week. And they had MONTHS! Wasn’t one report that like five or six months had gone by, and they had screen 17 people?? I mean, the “we are bit big pharma” thing was excusable for a while. But 1000 People?!! it almost seems like you could knock this out in one major city over the course of six months! It’s actually astounding how poorly this was done

User Image TheVixFix Posted - 2 days ago

$RVVTF sell your garbage shares and make your money back over at ATAI

User Image TheVixFix Posted - 2 days ago

$RVVTF Ouch!!!

User Image TheBigUglyBear Posted - 2 days ago

$RVVTF As I said before this stock is not worth more than .05 cents. With Tax harvesting and wash selling coming up this stock with dip even more from what is it now. This inept/dumb CEO has killed investor confidence. All he had to do was start the damn trial in Turkey and we”d have had 1000 patients by May 2022 and we would have known if it worked. But no he chose to extend the trial and go the BS “shortcut” route that is actually longer.

User Image PREPAREyourRUMP Posted - 2 days ago

$RVVTF this blows but gotta keep faith in results….invested to see buci results

User Image 2duhmooon Posted - 2 days ago

$RVVTF Hey guys, maybe I'm just some stupid dude. But Buci's IP if they were to sell it is surely worth more than the current 40mil market cap. Let's say nothing get approved, MF is revealed to be a paedo and we continue to be in a recession. How much lower could this company be worth. Surely there's a worse case based on the Buci rights?

User Image DrFever Posted - 2 days ago

$RVVTF https://youtu.be/bJuDD93JbOw

User Image BaronXXII Posted - 2 days ago

$RVVTF You know what this reminds me of? "Ladies & Gentlemen, Sam Bankman-Fried!" 🤦😡

User Image StuBeef Posted - 2 days ago

$RVVTF two week before it closes. Offering set at CAD$0.15 - US$0.11. So is that the floor or will it go lower?